David Snydman
Infectious Disease · Boston, MANPI 1942311337
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $140,085 of the $140,646 with a category attached, or 99.6%. 10 manufacturers reported payments, led by Modernatx, Inc. at 45.6% of the total. Among infectious disease clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 52 payments — averaging $2704.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$64K
- Takeda Pharmaceuticals U.S.A., Inc.$37K
- Merck$16K
- Shire North American Group Inc$9K
- Saol Therapeutics Inc.$4K
- Emergent Biosolutions Inc.$3K
- plus $7K from 4 others
Across 31 payments — averaging $79,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$2.3M
- Kamada Ltd.$73K
- Seqirus USA Inc$10K
- Takeda Pharmaceuticals U.S.A., Inc.$8K
- Shire North American Group Inc$6K
- Emergent Biosolutions Inc.$4K
What the payments were for
- Consulting fees$140,085100%
- Speaking & faculty fees$5500%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 24 | $64,150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $37,485 |
| Merck | 10 | $15,886 |
| Shire North American Group Inc | 3 | $9,275 |
| Saol Therapeutics Inc. | 2 | $3,550 |
| Emergent Biosolutions Inc. | 1 | $3,200 |
| Bavarian Nordic A/s | 2 | $2,800 |
| Seqirus USA Inc | 1 | $2,100 |
| Otsuka Pharmaceutical Co., Ltd. | 1 | $1,200 |
| Saol International Limited | 2 | $1,000 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$140,646 in reported general payments places this provider in the 95th percentile of 368 infectious disease providers in Massachusetts.
Other infectious disease in Boston
- Yoav GolanBoston$1.1M
- Nesli BasgozBoston$901K
- Todd EllerinBoston$843K
- Paul SaxBoston$320K
- Davidson HamerBoston$221K
- Camille KottonBoston$195K
- Eric RosenbergBoston$134K
- Deborah HungBoston$130K
- Laura KogelmanBoston$54K
- Jay FishmanBoston$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.